Antineoplastic Adverse Reaction
1 clinical trials · Condition
◉ Watch Antineoplastic Adverse Reaction
| Record | Firm | Date |
|---|---|---|
| Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia (NCT02244658) | Shandong University | 2014-09-01 |
Track Antineoplastic Adverse Reaction automatically
Every clearance here is in the API, with alerts when new ones post.